塔克罗利和环素A在接受脏移植的接受者中对抑郁症没有差异
Hongyang Chen1, Kepu Liu1, Di Wei1
1Department of Urology, Xijing Hospital, Air Force Medical University, Xi'an, China.
Transplantation proceedings
|September 24, 2023
概括
这项研究发现,在接受塔克罗利 (TAC) 或环素A (CsA) 的移植患者之间,抑郁率没有显著差异. 这两种氨酸抑制剂 (CNI) 对移植受体至关重要,这项研究澄清了它们对心理健康的比较影响.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 移植免疫学 移植免疫学
- 精神病学是一个精神病学.
背景情况:
- 氨酸抑制剂 (CNI),包括塔克罗利 (TAC) 和环素A (CsA),是移植接受者必需的免疫抑制剂.
- 塔克罗利 (TAC) 与抑郁症有关,作为潜在的不良影响,尽管据报道,其发病率很少与环素A (CsA) 相结合.
研究的目的:
- 为了比较脏移植接受者中抑郁症的患病率和严重程度,接受治疗的是塔克罗利斯 (TAC) 或环素A (CsA).
- 调查两组CNI之间的抑郁症得分和主要抑郁症率的潜在差异.
主要方法:
- 一项涉及接受TAC或CSA移植的脏移植患者的横截面研究.
- 抑郁症使用PHQ-9评分通过在线调查问卷进行评估,该调查问卷于2022年9月至12月进行.
- 倾向性得分匹配 (PSM) 用于在比较之前控制 TAC 和 CsA 组之间的基线特征差异.
主要成果:
- 总共分析了220个有效问卷,其中170个在TAC组,50个在CSA组.
- 在PSM之后,两组之间没有观察到基线特征的显著差异.
- 在接受TAC与CSA的接受者之间,PHQ-9分数,抑郁程度或严重抑郁率之间没有统计学上显著的差异.
结论:
- 用塔克罗利 (TAC) 和环素A (CsA) 治疗的移植接受者表现出类似的抑郁率.
- 该研究发现,这两种主要的氨酸抑制剂之间抑郁症严重程度或患病率没有显著差异.
相关概念视频
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
144
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
144
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
186
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
186
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
164
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
164
01:16Kidney Transplant III: Nursing Management
23
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
23
01:27Depressive Disorders: MDD and Dysthymia
149
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
149
01:26Kidney Transplant II: Surgical Procedure
22
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
22